Phenylethanolamine N-methyltransferase gene polymorphisms associate with crisis pain in sickle cell disease patients

Pharmacogenomics. 2020 Mar;21(4):269-278. doi: 10.2217/pgs-2019-0096. Epub 2020 Mar 12.

Abstract

Aim: Phenylethanolamine N-methyltransferase (PNMT) catalyzes the conversion of sympathetic neurotransmitter norepinephrine to epinephrine. We examined the association of PNMT polymorphisms with acute and chronic pain in sickle cell disease (SCD). Methods: Utilization of emergency care owing to painful crisis was used as a marker for acute pain in 131 patients with SCD. Results: rs876493 A allele, rs2934965 T allele and rs2941523 G allele were significantly associated with decreased utilization (p ≤ 0.05). rs876493 A allele showed association with utilization in females (p = 0.003), not males (p = 0.803). rs2934965 T allele and rs2941523 G allele were predicted to cause loss of putative transcription factor binding sites. This is the first report of the association of PNMT polymorphisms with acute crisis pain in SCD. Together with our previous findings in catechol-o-methyltransferase, polymorphisms in catecholamine metabolizing enzymes appear to primarily influence acute pain in SCD.

Keywords: PNMT; SNP; acute crisis pain; chronic pain; sickle cell disease.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Pain / genetics*
  • Adolescent
  • Adult
  • Aged
  • Alleles
  • Anemia, Sickle Cell / genetics*
  • Catechol O-Methyltransferase / genetics
  • Chronic Pain / genetics*
  • Female
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Phenylethanolamine N-Methyltransferase / genetics
  • Polymorphism, Single Nucleotide / genetics*
  • Young Adult

Substances

  • Phenylethanolamine N-Methyltransferase
  • Catechol O-Methyltransferase